Skip to main content
. 2022 Oct 7;83(6):626–634. doi: 10.1055/a-1920-0758

Table 1. Demographics and population characteristics of the entire cohort.

Demographic factor Entire cohort Control Intervention p -Value a
n (%) 542 409 (75.5%) 133 (24.5%)
Readmission, all cause 65 (12.0%) 57 (13.9%) 8 (6.0%) 0.015
Readmission, hyponatremia 20 (3.7%) 17 (4.2%) 3 (2.3%) 0.31
Admission age, y (mean ± SD) 54.0 ± 16.4 53.9 ± 16.5 54.6 ± 16.2 0.65
Female sex 294 (54.2%) 219 (53.5%) 75 (56.4%) 0.57
Race White 348 (64.2%) 262 (64.1%) 86 (64.7%) 0.99
African American 108 (19.9%) 82 (20.0%) 26 (19.5%)
Other 86 (15.9%) 65 (15.9%) 21 (15.8%)
Hispanic 224 (41.2%) 163 (39.8) 61 (45.9%) 0.221
BMI (mean ± SD) 30.0 ± 6.7 29.8 ± 6.7 30.4 ± 6.6 0.39
Functioning adenoma 158 (31.0%) 119 (39.2%) 39 (33.6%) 0.484
Tumor volume, cm 3 (mean ± SD) 12.8 ± 17.1 12.8 ± 16.9 12.7 ± 17.9 0.94
Intraoperative CSF leak Any leak 296 (54.6%) 218 (53.3%) 78 (58.6%) 0.28
Low-flow leak 199 (67.2%) 153 (70.2% 46 (59.0%) 0.10
High-flow leak 97 (32.8%) 65 (29.8%) 32 (41.0%)
Nasal septal flap 69 (12.9%) 50 (12.2%) 19 (15.2%) 0.39
Length of stay, d (mean ± SD) 2.7 ± 1.9 2.8 ± 2.1 2.5 ± 1.4 0.17
Endocrine, inpatient 467 (86.5%) 340 (83.3%) 127 (96.2%) <0.001
Endocrine, outpatient 380 (70.2%) 278 (68.0%) 102 (77.3%) 0.042
Type of outpatient endocrine Institution 229 (59.8%) 146 (52.1%) 83 (80.6%) <0.001
Private 154 (40.2%) 134 (47.9%) 20 (19.4%)
Postoperative diabetes insipidus 236 (43.9%) 183 (45.1%) 53 (40.2%) 0.32

Abbreviations: BMI, body mass index; CSF, cerebrospinal fluid; SD, standard deviation.

Note: Values presented as number (%) unless otherwise indicated. Bold indicates statistically significant p -Values.

a

Reflects two-tailed t -test for continuous variables or a Pearson's chi-square/Fisher's exact test to compare categorical data between the groups.